Login / Signup

Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer.

Yuko Tsuchiya-KawanoTomonari SasakiHiroyuki YamaguchiKatsuya HiranoAtsushi HoriikeMiyako SatouchiShinobu HosokawaRyotaro MorinagaKazutoshi KomiyaKoji InoueYuka FujitaRyo ToyozawaTomoki KimuraKosuke TakahashiKazuo NishikawaJunji KishimotoYoichi NakanishiIsamu Okamoto
Published in: The oncologist (2019)
Concurrent chemoradiation with nab-P/C was safe and provided a long-term survival benefit for patients with locally advanced NSCLC.
Keyphrases